3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Neoplasm Metastasis
3
Ovarian Neoplasms
2
Prostatic Neoplasms
1
Premenopausal Breast Cancer
1
Pancreatic Neoplasms
1
Invasive Early Breast Cancer
1
First Line Metastatic Breast Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Breast Cancer Metastatic
1
Interventions
enzalutamide
2
ostarine
1
nilutamide
1
exemestane
1
bicalutamide
1
apalutamide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Bulbo-Spinal Atrophy, X-Linked
×
exemestane
×
Clear all
NCT04869943
2024-01-26
ARTEST
Veru Inc.
Phase 3
Terminated
52 enrolled